Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | April 28, 2021 | News story | Research and Development | COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news
The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over its vaccine supplies, Bharat Biotech’s jab has shown 100% efficacy in a new trial, and an Antivirals Taskforce has been set up in the UK to find the most promising antiviral medicines.
1. European Commission sues AstraZeneca over COVID-19 jab supplies – Published 27/04/2021
The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 vaccines to EU countries.
2. Jubilant’s oral remdesivir formulation shows positive results in human trial – Published 22/04/21
Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an FDA-approved treatment for COVID-19.
3. Bharat Biotech jab shows 100% efficacy against severe COVID-19 – Published 22/04/21
Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, showed 100% efficacy against severe SARS-CoV-2 infection, with an overall efficacy of 78%.
4. J&J COVID-19 vaccine to resume Europe rollout – Published – 21/04/21
The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.
5. UK Government launches COVID-19 Antivirals Taskforce – Published 21/04/21
A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed to COVID-19, searching for the most promising novel antiviral medicines that can be taken at home, and supporting their development through clinical trials.
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
